Sucampo names new SVP of investor relations, PR, and corporate communicationsComtex News Network
Aug 25, 2012 (Datamonitor via COMTEX) --Sucampo Pharmaceuticals, Inc., a pharmaceutical company focused on the discovery, development of drugs based on prostones, has named Silvia Taylor as senior vice president, or SVP, of investor relations, public relations, or PR, and corporate communications. Ms Taylor will report to Cary Claiborne, CFO of the company.
Ms Taylor will lead the company's investor relations, public relations, media relations and internal communications efforts with responsibility to establish the corporate brand, and to enhance its presence among the investment audience and other stakeholder groups as well as in the different communities in which the company operates globally.
Ms Taylor joins Sucampo from MedImmune where she held positions of increasing responsibility, among them Senior Director of Marketing, RSV Franchise and Senior Director of Marketing, Global Influenza Franchise. Prior to MedImmune, Ms Taylor worked at Pfizer from 1999 to 2007, where she worked on Viagra and Exubera and in the company's consumer marketing department on patient-directed communications.
Ryuji Ueno, Chairman of the Board, CEO and CSO, said: "Ms Taylor brings extensive experience in large and mid-size public biopharmaceutical companies, and we look forward to her leadership in defining our corporate brand and overarching communications strategy among all of our corporate and product-related audiences. She will build upon the corporate awareness campaign we started earlier this month to increase awareness of Sucampo and our proprietary prostone technology."http://www.datamonitor.comRepublication or redistribution, including by framing or similar means,is expressly prohibited without prior written consent. Datamonitor shallnot be liable for errors or delays in the content, or for any actionstaken in reliance thereon